XML 85 R64.htm IDEA: XBRL DOCUMENT v3.25.0.1
Company financial information (Tables)
12 Months Ended
Dec. 31, 2024
Company financial information  
Schedule of statement of comprehensive income

Year ended December 31, 

2024

2023

2022

€’m

€’m

€’m

Other income

14

Other external charges

(2)

(2)

(3)

Finance (expense)/income

(22)

(5)

1

Loss before exceptional items

(10)

(7)

(2)

Exceptional operating income/(costs) (iv)

1

1

(2)

Exceptional finance income (iv)

13

55

210

Impairment of investments in subsidiary undertakings (v)

(400)

(Loss)/profit before tax

(396)

49

206

Income tax credit

3

(Loss)/profit and total comprehensive (expense)/income for the year

(393)

49

206

Schedule of statement of financial position

At December 31, 

2024

2023

€’m

€’m

Non-current assets

Investments in subsidiary undertakings

3,001

3,401

3,001

3,401

Current assets

Amounts receivable from subsidiary undertakings

15

Other receivables and prepayments

3

18

Total assets

3,019

3,401

Equity attributable to owners of the parent

Equity share capital

256

256

Share premium

5,097

5,097

Legal reserve

1

1

Other reserves

(1,832)

(1,832)

Retained earnings

(1,051)

(414)

Total equity

2,471

3,108

Non-current liabilities

Amounts payable to subsidiary undertakings

256

Amounts payable to related parties (vi)

9

21

Other liabilities (vii)

1

2

266

23

Current liabilities

Amounts payable to subsidiary undertakings

282

270

282

270

Total liabilities

548

293

Total equity and liabilities

3,019

3,401

Schedule of statement of cash flows

Year ended December 31, 

2024

2023

2022

€’m

€’m

€’m

Cash flows from operating activities

Cash used in operations

(2)

(2)

(4)

Net cash used in operating activities

(2)

(2)

(4)

Cash flows from financing activities

Proceeds from borrowings with subsidiary undertakings

245

246

35

Dividends paid (viii)

(243)

(244)

(244)

Proceeds from share issuance

247

Treasury shares purchased

(34)

Net cash inflow from financing activities

2

2

4

Net decrease in cash and cash equivalents

Cash and cash equivalents at the beginning of the year

Exchange gains on cash and cash equivalents

Cash and cash equivalents at end of year

Schedule of parent only financial information

Year ended December 31, 

2024

2023

2022

€'m

€'m

€'m

IFRS (loss)/profit reconciliation:

Parent only-IFRS (loss)/profit for the year

(393)

49

206

Additional gain/(loss) if subsidiaries had been accounted for using the equity method of accounting as opposed to cost

390

(95)

18

Consolidated IFRS (loss)/profit for the year

(3)

(46)

224

At December 31, 

2024

2023

€’m

€’m

IFRS equity reconciliation:

Parent only-IFRS equity

2,471

3,108

Additional loss if subsidiaries had been accounted for using the equity method of accounting as opposed to cost

(2,602)

(3,012)

Consolidated-IFRS equity

(131)

96

Year ended December 31, 

2024

2023

2022

$'m

$'m

$'m

IFRS (loss)/profit reconciliation:

Parent only-IFRS (loss)/profit for the year

(427)

53

218

Additional gain/(loss) if subsidiaries had been accounted for using the equity method of accounting as opposed to cost

424

(103)

19

Consolidated IFRS (loss)/profit for the year

(3)

(50)

237

At December 31, 

2024

2023

$'m

$'m

IFRS equity reconciliation:

Parent only-IFRS equity

2,567

3,434

Additional loss if subsidiaries had been accounted for using the equity method of accounting as opposed to cost

(2,703)

(3,328)

Consolidated-IFRS equity

(136)

106